Application of failure mode and effects analysis to treatment planning in scanned proton beam radiotherapy

Radiation Oncology

Volumn 8, Issue 1, 2013, Pages

  Cantone, Marie Claire ^a   Ciocca, Mario ^b   Dionisi, Francesco ^c   Fossati, Piero ^a,b   Lorentini, Stefano ^c   Krengli, Marco ^b,d   Molinelli, Silvia ^b   Orecchia, Roberto ^a,b   Schwarz, Marco ^c,e   Veronese, Ivan ^a   Vitolo, Viviana ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b Centro Nazionale Adroterapia Oncologica CNAO   (Italy)

^c Agenzia Provinciale per la Protonterapia   (Italy)

^d UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^e Azienda Provinciale per i Servizi Sanitari   (Italy)

Author keywords

Accidental exposures; FMEA; Patient safety; Protons; Risk assessment; Treatment planning

Indexed keywords

ARTICLE; ARTIFACT REDUCTION; CLINICAL ASSESSMENT TOOL; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; FAILURE MODE AND EFFECT ANALYSIS; HUMAN; IMAGE RECONSTRUCTION; PROSTHESIS; PROTON THERAPY; RADIATION EXPOSURE; RADIATION SAFETY; RISK ASSESSMENT; SCORING SYSTEM; TREATMENT PLANNING;

HUMANS; PROTON THERAPY; RADIATION INJURIES; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RISK ASSESSMENT; RISK MANAGEMENT;

EID: 84878006538     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-8-127     Document Type: Article

References (27)

1. Veronese I, Cantone MC, Chiodini N, Coray A, Fasoli M, Lomax A, Mones E, Moretti F, Vedda A. Feasibility study for the use of cerium-doped silica fibres in proton therapy. Radiat Meas 2010, 45:635-639.
2. Veronese I, Cantone MC, Catalano M, Chiodini N, Fasoli M, Mancosu P, Mones E, Moretti F, Scorsetti M, Vedda A. Study of the radioluminescene spectra of doped silica optical fibre dosimeters for stem effect removal. J Phys D: Appl Phys 2013, 46:015101.
3. Veronese I, Cantone MC, Chiodini N, Fasoli M, Mones E, Moretti F, Vedda A. The influence of the stem effect in Eu-doped silica optical fibres. Radiat Meas 2013, http://dx.doi.org/10.1016/j.radmeas.2013.01.043.
4. Mancosu P, Cozzi L, Fogliata A, Lattuada P, Reggiori G, Cantone MC, Navarria P, Scorsetti M. Collimator angle influence on dose distribution optimization for vertebral metastases using volumetric modulated arc therapy. Med Phys 2010, 37:4133-4137. 10.1118/1.3462560, 20879573.
5. Reggiori G, Mancosu P, Tozzi A, Cantone MC, Castiglioni S, Lattuada P, Lobefalo F, Cozzi L, Fogliata A, Navarria P, Scorsetti M. Cone beam CT pre- and post- daily treatment fot assessing geometrical and dosimetric intrafraction variability during radiotherapy of prostate cancer. J Appl Clin Med Phys 2011, 12:141-152.
6. World Health Organization Radiotherapy Risk Profile 2008, Geneva: WHO/IER/PSP/2008.12, World Health Organization.
7. International Atomic Energy Agency Lessons learned from accidents in radiotherapy 2000, Vienna: IAEA (Safety Reports Series 17), International Atomic Energy Agency.
8. International Commission on Radiological Protection Preventing Accidental Exposures from New External Beam Radiation Therapy Technologies 2009, Elsevier, ICRP Publication 112, Annals of the ICRP 39 (4), International Commission on Radiological Protection.
9. Ford EC, Gaudette R, Myers L, Vanderver B, Engineer L, Zellars R, Song DY, Wong J, DeWeese TL. Evaluation of safety in radiation oncology setting using failure mode and effects analysis. Int J Radiat Oncol Biol Phys 2009, 74:852-858. 10.1016/j.ijrobp.2008.10.038, 3655406, 19409731.
10. Ekaette EU, Lee RC, Cooke DL, Iftody S, Craighead P. Probabilistic fault tree analysis of a radiation treatment system. Risk Anal 2007, 27:1395-1410. 10.1111/j.1539-6924.2007.00976.x, 18093042.
11. Ciocca M, Cantone MC, Veronese I, Cattani F, Petroli G, Molinelli S, Vitolo V, Orecchia R. Application of failure mode and effect analysis to intraoperative radiation therapy using mobile electron linear accelerators. Int J Radiat Oncol Biol Phys 2012, 82:e305-e311. 10.1016/j.ijrobp.2011.05.010, 21708432.
12. Perks JR, Stanic S, Stern RL, Henk B, Nelson MS, Harse Mathai M, Purdy J, Valicenti RK, Siefkin AD, Chen AM. Failure mode and effect analysis for delivery of lung stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2012, 83:1324-1329. 10.1016/j.ijrobp.2011.09.019, 22197236.
13. Sawant A, Dieterich S, Svatos M, Keall P. Failure mode and effect analysis-based quality assurance for dynamic MLC tracking systems. Med Phys 2010, 37:6466-6479. 10.1118/1.3517837, 3016096, 21302802.
14. Huq MS, Fraass BA, Dunscombe PB, Gibbons JP, Ibbott GS, Medin PM, Mundt A, Mutic S, Palta JR, Thomadsen BR, Williamson JF, Yorke ED. A method for evaluating quality assurance needs in radiation therapy. Int J Radiat Oncol Biol Phys 2008, 71(Suppl):S170-S173.
15. Rossi S. The status of CNAO Eur Phys J Plus 2011, 126:78.
16. Orecchia R, Fossati P, Rossi S. The national center for oncological hadron therapy: status of the project and future clinical use of the facility. Tumori 2009, 95:169-176.
17. Giordanengo S, Donetti M, Garella MA, Marchetto F, Alampi G, Ansarinejad A, Monaco V, Mucchi M, Pecka IA, Peroni C, Sacchi R, Scalise M, Tomba C, Cirio R. Design and characterization of the beam monitor detectors of the Italian National Center of Oncological Hadron-therapy (CNAO). Nucl Instrum Meth A 2013, 698:202-207.
18. Lomax A. Intensity modulation methods for proton radiotherapy. Phys Med Biol 1999, 44:185-205. 10.1088/0031-9155/44/1/014, 10071883.
19. Bert C, Durante M. Motion in radiotherapy: particle therapy. Phys Med Biol 2011, 56:R113-R144. 10.1088/0031-9155/56/16/R01, 21775795.
20. Albertini F, Casiraghi M, Lorentini S, Rombi B, Lomax AJ. Experimental verification of IMPT treatment plans in an anthropomorphic phantom in the presence of delivery uncertainties. Phys Med Biol 2011, 56:4415-4431. 10.1088/0031-9155/56/14/012, 21709345.
21. Unkelbach J, Bortfeld T, Martin BC, Soukup M. Reducing the sensitivity of IMPT treatment plans to setup errors and range uncertainties via probabilistic treatment planning. Med Phys 2009, 36:149-163. 10.1118/1.3021139, 2673668, 19235384.
22. Fredriksson A, Forsgren A, Hardemark B. Minimax optimization for handling range and setup uncertainties in proton therapy. Med Phys 2011, 38:1672-1684. 10.1118/1.3556559, 21520880.
23. Paganetti H. Range uncertainties in proton therapy and the role of Monte Carlo simulations. Phys Med Biol 2012, 57:R99-R117. 10.1088/0031-9155/57/11/R99, 22571913.
24. Pflugfelder D, Wilkens JJ, Oelfke U. Worst case optimization: a method to account for uncertainties in the optimization of intensity modulated proton therapy. Phys Med Biol 2008, 53:1689-1700. 10.1088/0031-9155/53/6/013, 18367797.
25. Chen W, Unkelbach J, Trofimov A, Madden T, Kooy H, Bortfeld T, Craft D. Including robustness in multi-criteria optimization for intensity-modulated proton therapy. Phys Med Biol 2012, 57:591-608. 10.1088/0031-9155/57/3/591, 3360481, 22222720.
26. Albertini F, Hug EB, Lomax AJ. The influence of the optimization starting conditions in the robustness of intensity-modulated proton therapy plans. Phys Med Biol 2010, 55:2863-2878. 10.1088/0031-9155/55/10/005, 20427853.
27. Parodi K, Mairani A, Brons S, Hasch BG, Sommerer F, Naumann J, Jäkel O, Haberer T, Debus J. Monte Carlo simulations to support start-up and treatment planning of scanned proton and carbon ion therapy at a synchrotron-based facility. Phys Med Biol 2012, 57:3759-3784. 10.1088/0031-9155/57/12/3759, 22617050.